Skip to content

CBT4CBT With Spanish Alcohol Users

Computer Based Training in CBT for Spanish-Speaking Alcohol Users

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03474588
Enrollment
51
Registered
2018-03-22
Start date
2019-08-06
Completion date
2023-08-16
Last updated
2024-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder

Brief summary

Specific aims are as follows: * To adapt our existing CBT4CBT program for use with Spanish-speaking alcohol users in a web-based platform * To conduct an 8-week randomized trial evaluating the feasibility and efficacy of adding CBT4CBT-Spanish to treatment as usual in a community based treatment program in a population of 90 Spanish-speaking individuals who meet current criteria for alcohol use disorder * To evaluate the long-term durability and/or delayed emergence of treatment effects through a six month follow-up after termination of the study treatments. Given previous evidence regarding the durability of standard clinician-delivered CBT and computer-assisted CBT4CBT, we hypothesize that CBT4CBTSpanish will be significantly more effective than standard treatment alone through the follow-up.

Detailed description

The investigators will conduct a Stage 1 randomized clinical trial evaluating the program in which 90 Spanish-speaking individuals with alcohol use disorder will be randomized to (1) standard outpatient counseling at the Hispanic Clinic (ST; typically consisting of weekly individual and group supportive counseling) or (2) CBT4CBT-Spanish as an adjunct to ST. Other aspects of the trial will parallel those in the investogators completed trial of the English version of CBT4CBT-Alcohol to facilitate comparability across studies. Treatments will be delivered over an 8-week period with a 6-month follow-up to assess durability and/or delayed emergence of treatment effects. The primary outcome measure will be percent days of abstinence (PDA) by week. Secondary outcomes include percent heavy drinking days and number of individuals with no heavy drinking days in the last 4 weeks of treatment. Participants will be 90 individuals seeking treatment for alcohol use at the Hispanic Clinic of CMHC. The clinic treats a heterogeneous population, where 42% of those in the co-occurring treatment program report alcohol as their principal substance related issue and 43% are women. As reported above, the investigators have demonstrated the ability to recruit, randomize, retain, and follow-up high numbers of closely related samples in this setting.

Interventions

BEHAVIORALStandard treatment (ST) PLUS web-based CBT4CBT

Participants will have access to the CBT4CBT website in Spanish as an add-on to treatment. In this treatment participants will work with a computerized program that teaches skills for stopping alcohol use and increasing coping skills, such as how to understand patterns of alcohol use, how to cope with cravings for alcohol, how to refuse offers of alcohol, and so on

ST includes individual and group therapy sessions and regular urine monitoring. Sessions will generally last for 1 hour one time per week for 8 weeks

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Are 18 years of age or older. 2. Are applying for outpatient alcohol treatment, with some alcohol use in the past 30 days 3. Speak Spanish as their preferred or principal (most commonly spoken) language. 4. Are sufficiently stable for 8 weeks of outpatient treatment 5. Can commit to 8 weeks of treatment and are willing to be randomized to treatment 6. Are willing to provide locator information for follow-up.

Exclusion criteria

1. Have an untreated bipolar or schizophrenic disorder 2. Have a current legal case pending such that incarceration during the 8 week protocol is likely 3. Meet DSM-5 criteria for another current substance use disorder (other than nicotine).

Design outcomes

Primary

MeasureTime frameDescription
The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by WeekBy week for 8 weeksThe primary outcome measure will be percent days of abstinence (PDA) by week, presented are the raw means at each time point.
Monthly Abstinence From AlcoholMonths 3 through 8 (6 months total)Estimated means of sustained abstinence calculated as percent days per month from month 3 through 8 in post intervention follow up.

Secondary

MeasureTime frameDescription
Secondary Outcomes Include Percent Heavy Drinking Days8 weeksPercent heavy drinking days during 8 weeks of trial
Number of Individuals With no Heavy Drinking Days in the Last 4 Weeks of Treatmentlast 4 weeks of treatment (4 weeks)Number of individuals with no heavy drinking days in the last 4 weeks of treatment

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard Treatment (ST)
This is the same as the treatment normally received at this clinic. This will be tailored to participants' needs, but generally includes individual and group therapy sessions and regular urine monitoring. Sessions will generally last for 1 hour one time per week for 8 weeks and include issues such as: * Teaching about the treatment program * Teaching important ideas about recovery * Increasing knowledge about specific problems about addiction * Demonstrating new ways of coping with skills designed to fit each participant Standard Treatment (ST): ST includes individual and group therapy sessions and regular urine monitoring. Sessions will generally last for 1 hour one time per week for 8 weeks
28
Standard Treatment (ST) PLUS Web-based CBT4CBT
This is the same as the treatment normally received at this clinic. This will be tailored to participants' needs, but generally includes individual and group therapy sessions and regular urine monitoring. Sessions will generally last for 1 hour one time per week for 8 weeks and include issues such as: * Teaching about the treatment program * Teaching important ideas about recovery * Increasing knowledge about specific problems about addiction * Demonstrating new ways of coping with skills designed to fit each participant PLUS Participants will have access the CBT4CBT website in Spanish as an add-on to treatment. In this treatment participants will work with a computerized program that teaches skills for stopping alcohol use and increasing coping skills, such as how to understand patterns of alcohol use, how to cope with cravings for alcohol, how to refuse offers of alcohol, and so on. Standard treatment (ST) PLUS web-based CBT4CBT: Participants will have access to the CBT4CBT website in Spanish as an add-on to treatment. In this treatment participants will work with a computerized program that teaches skills for stopping alcohol use and increasing coping skills, such as how to understand patterns of alcohol use, how to cope with cravings for alcohol, how to refuse offers of alcohol, and so on
23
Total51

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath01
Overall StudyWithdrawal by Subject43

Baseline characteristics

CharacteristicStandard Treatment (ST)Standard Treatment (ST) PLUS Web-based CBT4CBTTotal
Age, Continuous39.5 years
STANDARD_DEVIATION 13
44.8 years
STANDARD_DEVIATION 11.9
41.9 years
STANDARD_DEVIATION 12.7
Age first used alcohol17.1 years
STANDARD_DEVIATION 4.9
17.5 years
STANDARD_DEVIATION 6.8
17.3 years
STANDARD_DEVIATION 5.8
Alcohol Use Disorder (AUD) Severity Rating
Mild
0 Participants1 Participants1 Participants
Alcohol Use Disorder (AUD) Severity Rating
Moderate
7 Participants6 Participants13 Participants
Alcohol Use Disorder (AUD) Severity Rating
Severe
21 Participants16 Participants37 Participants
Alcohol Use Disorders Identification Test (Audit) Score 16 or higher18 Participants14 Participants32 Participants
Client Origin of birth
Client
Carribean Island
0 Participants1 Participants1 Participants
Client Origin of birth
Client
Mexico
14 Participants6 Participants20 Participants
Client Origin of birth
Client
Other Central American country
5 Participants6 Participants11 Participants
Client Origin of birth
Client
Puerto Rico
7 Participants7 Participants14 Participants
Client Origin of birth
Client
South American country
1 Participants2 Participants3 Participants
Client Origin of birth
Client
United States
1 Participants1 Participants2 Participants
Client Origin of birth
Father
Carribean Island
0 Participants1 Participants1 Participants
Client Origin of birth
Father
Mexico
14 Participants6 Participants20 Participants
Client Origin of birth
Father
Other Central American country
6 Participants7 Participants13 Participants
Client Origin of birth
Father
Puerto Rico
7 Participants7 Participants14 Participants
Client Origin of birth
Father
South American country
1 Participants2 Participants3 Participants
Client Origin of birth
Father
United States
0 Participants0 Participants0 Participants
Client Origin of birth
Mother
Carribean Island
0 Participants1 Participants1 Participants
Client Origin of birth
Mother
Mexico
14 Participants6 Participants20 Participants
Client Origin of birth
Mother
Other Central American country
6 Participants7 Participants13 Participants
Client Origin of birth
Mother
Puerto Rico
7 Participants7 Participants14 Participants
Client Origin of birth
Mother
South American country
1 Participants2 Participants3 Participants
Client Origin of birth
Mother
United States
0 Participants0 Participants0 Participants
Completed High School12 Participants12 Participants24 Participants
Current anxiety disorder4 Participants3 Participants7 Participants
Current major depression10 Participants11 Participants21 Participants
Current PTSD by SCID3 Participants6 Participants9 Participants
Days of alcohol use in the past 289.1 days
STANDARD_DEVIATION 9.3
7.7 days
STANDARD_DEVIATION 7.3
8.5 days
STANDARD_DEVIATION 8.4
Days of heavy alcohol use in the past 287 days
STANDARD_DEVIATION 8.7
5.4 days
STANDARD_DEVIATION 6.4
6.3 days
STANDARD_DEVIATION 7.7
Days paid for work in past 2814.1 days
STANDARD_DEVIATION 11.6
10.7 days
STANDARD_DEVIATION 10.1
12.6 days
STANDARD_DEVIATION 11
Diagnosed PTSD by PCL-55 Participants5 Participants10 Participants
Drinks per drinking days in the past 288.6 drinks
STANDARD_DEVIATION 5.9
10.9 drinks
STANDARD_DEVIATION 14.1
9.6 drinks
STANDARD_DEVIATION 10.4
Ethnicity (NIH/OMB)
Hispanic or Latino
28 Participants23 Participants51 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Lifetime anxiety disorder5 Participants6 Participants11 Participants
Lifetime major depression16 Participants11 Participants27 Participants
Lifetime PTSD by SCID3 Participants7 Participants10 Participants
Never married/living alone15 Participants19 Participants34 Participants
On parole or probation7 Participants8 Participants15 Participants
On Public Assistance10 Participants6 Participants16 Participants
Percent days of alcohol abstinence at week 073.5 percentage of days
STANDARD_DEVIATION 35.4
77 percentage of days
STANDARD_DEVIATION 25.8
75.1 percentage of days
STANDARD_DEVIATION 31.1
Percent days of alcohol abstinence in the past 2867.5 percentage of days
STANDARD_DEVIATION 33.2
72.4 percentage of days
STANDARD_DEVIATION 26.2
69.7 percentage of days
STANDARD_DEVIATION 30
Percent days of heavy drinking at week 020.4 percentage of days
STANDARD_DEVIATION 32.2
14.9 percentage of days
STANDARD_DEVIATION 20.9
17.9 percentage of days
STANDARD_DEVIATION 27.5
Percent days of heavy drinking in the past 2825.2 percentage of days
STANDARD_DEVIATION 31.1
19.3 percentage of days
STANDARD_DEVIATION 23
22.5 percentage of days
STANDARD_DEVIATION 27.6
Pre-treatment Alcohol Symptom Count7.7 symptom count
STANDARD_DEVIATION 2.4
7.6 symptom count
STANDARD_DEVIATION 2.6
7.7 symptom count
STANDARD_DEVIATION 2.5
Pre-treatment AUDIT Score20.3 score on a scale
STANDARD_DEVIATION 9.2
18.9 score on a scale
STANDARD_DEVIATION 7.7
19.7 score on a scale
STANDARD_DEVIATION 8.5
Previous computer experience21 Participants12 Participants33 Participants
Referred by criminal justice system7 Participants10 Participants17 Participants
Region of Enrollment
United States
28 participants23 participants51 participants
Sex: Female, Male
Female
11 Participants5 Participants16 Participants
Sex: Female, Male
Male
17 Participants18 Participants35 Participants
Unemployed10 Participants9 Participants19 Participants
Years living in United States19.5 years
STANDARD_DEVIATION 14
19.2 years
STANDARD_DEVIATION 10
19.3 years
STANDARD_DEVIATION 12.2
Years of alcohol use21.1 years
STANDARD_DEVIATION 13.2
25.8 years
STANDARD_DEVIATION 14.9
23.2 years
STANDARD_DEVIATION 14

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 281 / 23
other
Total, other adverse events
0 / 280 / 23
serious
Total, serious adverse events
2 / 284 / 23

Outcome results

Primary

Monthly Abstinence From Alcohol

Estimated means of sustained abstinence calculated as percent days per month from month 3 through 8 in post intervention follow up.

Time frame: Months 3 through 8 (6 months total)

Population: All participants assessed during the period.

ArmMeasureGroupValue (MEAN)Dispersion
Standard Treatment (ST) PLUS Web-based CBT4CBTMonthly Abstinence From Alcoholmonth 489.85 percentage of days abstinent in a monthStandard Deviation 10.55
Standard Treatment (ST) PLUS Web-based CBT4CBTMonthly Abstinence From Alcoholmonth 691.49 percentage of days abstinent in a monthStandard Deviation 10.55
Standard Treatment (ST) PLUS Web-based CBT4CBTMonthly Abstinence From Alcoholmonth 389.03 percentage of days abstinent in a monthStandard Deviation 10.55
Standard Treatment (ST) PLUS Web-based CBT4CBTMonthly Abstinence From Alcoholmonth 792.30 percentage of days abstinent in a monthStandard Deviation 10.55
Standard Treatment (ST) PLUS Web-based CBT4CBTMonthly Abstinence From Alcoholmonth 590.67 percentage of days abstinent in a monthStandard Deviation 10.55
Standard Treatment (ST) PLUS Web-based CBT4CBTMonthly Abstinence From Alcoholmonth 893.12 percentage of days abstinent in a monthStandard Deviation 10.55
Standard Treatment (ST)Monthly Abstinence From Alcoholmonth 576.31 percentage of days abstinent in a monthStandard Deviation 29.3
Standard Treatment (ST)Monthly Abstinence From Alcoholmonth 377.46 percentage of days abstinent in a monthStandard Deviation 29.3
Standard Treatment (ST)Monthly Abstinence From Alcoholmonth 476.88 percentage of days abstinent in a monthStandard Deviation 29.3
Standard Treatment (ST)Monthly Abstinence From Alcoholmonth 874.59 percentage of days abstinent in a monthStandard Deviation 29.3
Standard Treatment (ST)Monthly Abstinence From Alcoholmonth 675.74 percentage of days abstinent in a monthStandard Deviation 29.3
Standard Treatment (ST)Monthly Abstinence From Alcoholmonth 775.17 percentage of days abstinent in a monthStandard Deviation 29.3
Comparison: Random Effects Regression Model (RERM), included in the model were treatment, time and the interaction of time and treatment.p-value: 0.1495% CI: [-0.46, 3.24]Regression, Linear
Primary

The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Week

The primary outcome measure will be percent days of abstinence (PDA) by week, presented are the raw means at each time point.

Time frame: By week for 8 weeks

Population: One participant was lost to follow up beginning week 4 in the Standard treatment (ST) PLUS web-based CBT4CBT.

ArmMeasureGroupValue (MEAN)Dispersion
Standard Treatment (ST) PLUS Web-based CBT4CBTThe Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 0 (baseline)73.29 percentage of days abstinent per weekStandard Deviation 25.71
Standard Treatment (ST) PLUS Web-based CBT4CBTThe Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 283.23 percentage of days abstinent per weekStandard Deviation 22.65
Standard Treatment (ST) PLUS Web-based CBT4CBTThe Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 188.20 percentage of days abstinent per weekStandard Deviation 19.57
Standard Treatment (ST) PLUS Web-based CBT4CBTThe Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 391.30 percentage of days abstinent per weekStandard Deviation 11.98
Standard Treatment (ST) PLUS Web-based CBT4CBTThe Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 490.26 percentage of days abstinent per weekStandard Deviation 15.52
Standard Treatment (ST) PLUS Web-based CBT4CBTThe Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 592.86 percentage of days abstinent per weekStandard Deviation 12.27
Standard Treatment (ST) PLUS Web-based CBT4CBTThe Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 689.61 percentage of days abstinent per weekStandard Deviation 14.74
Standard Treatment (ST) PLUS Web-based CBT4CBTThe Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 787.01 percentage of days abstinent per weekStandard Deviation 24.11
Standard Treatment (ST) PLUS Web-based CBT4CBTThe Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 884.42 percentage of days abstinent per weekStandard Deviation 22.44
Standard Treatment (ST)The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 680.10 percentage of days abstinent per weekStandard Deviation 29.7
Standard Treatment (ST)The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 471.43 percentage of days abstinent per weekStandard Deviation 30.61
Standard Treatment (ST)The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 278.06 percentage of days abstinent per weekStandard Deviation 29.22
Standard Treatment (ST)The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 572.45 percentage of days abstinent per weekStandard Deviation 28.29
Standard Treatment (ST)The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 0 (baseline)66.96 percentage of days abstinent per weekStandard Deviation 34.59
Standard Treatment (ST)The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 875.51 percentage of days abstinent per weekStandard Deviation 31.55
Standard Treatment (ST)The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 179.59 percentage of days abstinent per weekStandard Deviation 30.97
Standard Treatment (ST)The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 777.04 percentage of days abstinent per weekStandard Deviation 31.67
Standard Treatment (ST)The Primary Outcome Measure Will be Percent Days of Abstinence (PDA) by Weekweek 377.55 percentage of days abstinent per weekStandard Deviation 31.69
p-value: 0.3Regression, Linear
Secondary

Number of Individuals With no Heavy Drinking Days in the Last 4 Weeks of Treatment

Number of individuals with no heavy drinking days in the last 4 weeks of treatment

Time frame: last 4 weeks of treatment (4 weeks)

Population: Participants completing the study.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard Treatment (ST) PLUS Web-based CBT4CBTNumber of Individuals With no Heavy Drinking Days in the Last 4 Weeks of Treatment11 Participants
Standard Treatment (ST)Number of Individuals With no Heavy Drinking Days in the Last 4 Weeks of Treatment13 Participants
p-value: 0.802Chi-squared
Secondary

Secondary Outcomes Include Percent Heavy Drinking Days

Percent heavy drinking days during 8 weeks of trial

Time frame: 8 weeks

Population: Participants completing the full study.

ArmMeasureValue (MEAN)Dispersion
Standard Treatment (ST) PLUS Web-based CBT4CBTSecondary Outcomes Include Percent Heavy Drinking Days6.4 percentage of heavy drinking daysStandard Deviation 10.3
Standard Treatment (ST)Secondary Outcomes Include Percent Heavy Drinking Days15.2 percentage of heavy drinking daysStandard Deviation 22.7
p-value: 0.097ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026